You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

ESOMEPRAZOLE STRONTIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Esomeprazole Strontium patents expire, and when can generic versions of Esomeprazole Strontium launch?

Esomeprazole Strontium is a drug marketed by Belcher and is included in one NDA.

The generic ingredient in ESOMEPRAZOLE STRONTIUM is esomeprazole strontium. There are seventy-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the esomeprazole strontium profile page.

US Patents and Regulatory Information for ESOMEPRAZOLE STRONTIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belcher ESOMEPRAZOLE STRONTIUM esomeprazole strontium CAPSULE, DELAYED RELEASE;ORAL 202342-001 Aug 6, 2013 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Belcher ESOMEPRAZOLE STRONTIUM esomeprazole strontium CAPSULE, DELAYED RELEASE;ORAL 202342-002 Aug 6, 2013 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.